BANK OF MONTREAL /CAN/ - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 130 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 3.37 and the average weighting 0.9%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$109,000
+67.7%
3,184
-24.6%
0.00%
Q2 2020$65,000
+828.6%
4,221
+744.2%
0.00%
Q1 2020$7,000
-96.9%
500
-92.7%
0.00%
Q4 2019$228,000
+121.4%
6,822
+39.3%
0.00%
Q3 2019$103,000
+14.4%
4,897
+12.2%
0.00%
Q2 2019$90,000
+309.1%
4,363
+336.3%
0.00%
Q1 2019$22,000
-40.5%
1,000
-34.0%
0.00%
Q4 2018$37,000
+32.1%
1,516
+47.9%
0.00%
Q3 2018$28,000
-39.1%
1,025
-40.9%
0.00%
Q2 2018$46,000
+2.2%
1,734
+23.9%
0.00%
Q1 2018$45,000
-15.1%
1,4000.0%0.00%
Q4 2017$53,0001,4000.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders